Reduce Cost of Poor QualityRestore Execution Stability
GMPKit is a specialist consultancy that reduces Cost of Poor Quality in pharmaceutical manufacturing. We lead implementation with site leadership to correct execution failure and restore stability in 90–120 days. We implement structural change—not just recommendations.
15–20%
Recoverable COPQ
90–120 Days
Time to measurable results
3 Continents
Clients served globally
AI Decision Support for GMP Professionals
Makes you stronger, not weaker.
Built to improve how GMP professionals think, structure, and communicate—not replace their expertise.
Better thinking. Better structure. Better outcomes.
What Creates Cost of Poor Quality?
Cost of Poor Quality (COPQ) is the measurable financial impact of structural execution failures—including lost batches, delayed disposition, deviation backlog, rework, and constrained manufacturing capacity.
How GMPKit Delivers Results
See why pharmaceutical manufacturers trust GMPKit to restore execution stability
Structural COPQ Diagnosis
We identify where execution friction is generating the largest financial losses — using diagnostic routines, COPQ quantification, and constraint analysis.
Implementation Ownership
We own implementation with site leadership through our operating model. We do not advise and exit — we implement structural correction and measure results.
Governance Discipline That Sustains Results
Operational stability is not an outcome—it is a governance discipline. We build the systems that prevent regression after the engagement ends.
Want to see how this works in practice?
View Our Engagement Journey →Every GMPKit engagement runs through a structured 6-Stage Operating Model — the mechanism that takes a site from COPQ diagnosis through implementation and into sustained governance.
Explore the Operating ModelDeviation Backlog Recovery
Cell therapy CDMO • 120-day engagement • May 2026
Operational & financial impact recovered
Deviation backlog eliminated
Clinical supply restored
Client confidence rebuilt
Explore additional operational recovery engagements across pharmaceutical manufacturing, including measurable improvements in batch success, backlog reduction, inspection readiness, and execution stability.
Ready to Restore Execution Stability?
Start with a diagnostic call to identify where execution friction is generating Cost of Poor Quality—or calculate the financial impact first.